Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07355348

Codesign of a Cognitive Stepped Care Program to Enhance Quality of Life in Adults With Brain Metastases: Evaluation of Feasibility, Acceptability, and Preliminary Efficacy

Led by University Health Network, Toronto · Updated on 2026-01-21

140

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cognitive symptoms are common and often severe in patients with brain metastases, affecting their quality of life and ability to manage cancer care. Currently, no standard method exists for routine assessment and management of these symptoms in oncology clinics. This study evaluates the feasibility, acceptability, and early effectiveness of the Cognitive Stepped Care Program (CSCP) in a Brain Metastases Clinic setting. The Cognitive Stepped Care Program involves two key steps: first, patients complete a 10-item cognitive symptom screening tool that rates symptoms from 0 to 10 to identify severity. Based on the screening results, patients receive tailored interventions ranging from no support for no symptoms, educational materials for mild symptoms, to computerized cognitive testing with individualized feedback for moderate to severe symptoms. Additional group strategy training or neuropsychological consultations may be provided as needed. Participants will complete questionnaires before and after the intervention to report their symptoms and quality of life. Feedback will also be gathered from patients, caregivers, and clinic staff through questionnaires and interviews. The study measures include intervention completion and satisfaction rates, recruitment and retention rates, and preliminary changes in cognitive symptoms, self-efficacy, and cancer-related quality of life. The study duration averages around one month for intervention completion, with follow-up for up to four months and adoption and implementation factors monitored up to one year.

CONDITIONS

Brief Title

Feasibility of a Cognitive Stepped Care Program for Adults With Brain Metastases

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with brain metastasis from any primary cancer
  • Receiving follow-up care in the Brain Metastases Clinic
  • Adult aged 18 years or older
  • Able to speak, read, and write in English
  • Able to provide written informed consent
Not Eligible

You will not qualify if you...

  • History of significant developmental or learning disability, psychiatric disorder, or acquired neurological disorder such as traumatic brain injury
  • Poor performance status (ECOG 3 or higher)
  • Life expectancy less than 3 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Cognitive Stepped Care Program

Duration - Approximately 1 month

Participants complete a cognitive symptom screening and receive tailored cognitive symptom management based on their symptom severity, which may include educational materials, computerized cognitive testing, and group strategy training or neuropsychological consultation as needed.

1 baseline visit and follow-up visits as needed during the month

Follow-up

Duration - Up to 1 year

Participants are monitored for changes in cognitive symptoms, self-efficacy, and quality of life up to 4 months, with additional assessments related to intervention adoption and implementation up to 1 year.

Periodic follow-up visits up to 1 year

Trial Site Locations

Total: 1 location

1

Princess Margaret Cancer Centre, University Health Network

Toronto, Ontario, Canada, M5G 2M9

Actively Recruiting

Loading map...

Research Team

S

Samantha Mayo, RN, PhD

S

Stacey Morrison, MSc, CCRP

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Similar Trials

Use of 18F-Fluciclovine PET to Identify Tumors in Patients W...

Brain Metastasis

Actively Recruiting

1 location

18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastas...

Brain Metastases

Actively Recruiting

1 location

7T Brain MRI Scan for Micro-brain Metastasis Detection in Pa...

Small-cell Lung Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here